Abbott Park, IL - Abbott Laboratories announced the launch of the next-generation Perclose ® suture-mediated vessel closure system, Perclose ProGlide TM, featuring a polypropylene monofilament suture.
Use of the Perclose ProGlide suture-mediated closure strategy to achieve vascular access-site hemostasis after transfemoral TAVR results in fewer major vascular complications than does deployment of ...
Abbott declared the 371st consecutive quarterly dividend of 26 cents per share on Sept. 15. The current dividend yield is 2.60%. The company is a long-term dividend payer and has increased its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results